Levobupivacaine hydrochloride
SIGMA/SML1092 - ≥98% (HPLC)
Synonym: (S)
CAS Number: 27262-48-2
Empirical Formula (Hill Notation): C18H28N2O · HCl
Molecular Weight: 324.89
MDL Number: MFCD01704265
Linear Formula: C18H28N2O · HCl
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C18H28N2O.ClH/c1-4-5-1 |
InChI key | SIEYLFHKZGLBNX-NTISSMGPSA |
optical activity | [α]/D -10 to -14°, c = 1.0 in H2O |
Quality Level | 100 |
SMILES string | CC1=C(NC([C@H]2N(CCCC)CCC |
solubility | H2O: 20 mg/mL, clear |
storage condition | desiccated |
storage temp. | 2-8°C |
Application: | Levobupivacaine hydrochloride has been used as an analyte in tandem mass spectrometry. It may be used to test its inhibitory effect on phosphorylation of extracellular signal-regulated kinase (ERK) mediated by capsaicin It may also be used as a component of poly( |
Biochem/physiol Actions: | Levobupivacaine hydrochloride is a sodium channel blocker used as a long-acting local anaesthetic for epidural anesthesia. Levobupivacaine is the (S)-isomer of bupivacaine, with efficacy similar to that of bupivacaine with a reduced risk of cardiotoxicity. |
Biochem/physiol Actions: | Levobupivacaine mediates its action by blocking the action potential and sodium passage in neuronal membrane. |
General description: | Levobupivacaine belongs to the N-alkyl substituted pipecoloxylidide family and comprises amino-amide group. |
Packaging: | 10, 50 mg in glass bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P302 + P352 - P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |